“Formulation Designing Factors for Development of Repaglinide Transdermal Therapeutic System”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 2, pp. 148–158, Mar. 2020, doi: 10.25004/IJPSDR.2020.120209.